Inventor · disambiguated record
Anu Wallecha
Also filed as: WALLECHA ANU
10 granted patents·16 pending applications·101 citations·filing 2009–2025
89Inventor score
Top patents by PatentIndex Score
26 records- 0190US9650639B2Dual delivery system for heterologous antigensADVAXIS INC·Filed 2014·Granted May 16, 2017·11 cites·18 claims
- 0290US9017660B2Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumorsSHAHABI VAFA·Filed 2011·Granted Apr 28, 2015·22 cites·61 claims
- 0388US11179339B2Compositions and methods for lyophilization of bacteria or listeria strainsADVAXIS INC·Filed 2018·Granted Nov 23, 2021·4 cites·26 claims
- 0488US9644212B2Dual delivery system for heterologous antigensADVAXIS INC·Filed 2014·Granted May 9, 2017·11 cites·10 claims
- 0588US9463227B2Listeria-based adjuvantsROTHMAN JOHN·Filed 2012·Granted Oct 11, 2016·18 cites·15 claims
- 0687US10258679B2Recombinant Listeria vaccine strains and methods of producing the sameADVAXIS INC·Filed 2015·Granted Apr 16, 2019·6 cites·32 claims
- 0787US10064898B2Listeria-based adjuvantsADVAXIS INC·Filed 2016·Granted Sep 4, 2018·7 cites·14 claims
- 0887US9084747B2Compositions and methods for prevention of escape mutation in the treatment of HER2/NEU over-expressing tumorsSHAHABI VAFA·Filed 2010·Granted Jul 21, 2015·16 cites·25 claims
- 0980US10058599B2Suppressor cell function inhibition following Listeria vaccine treatmentADVAXIS INC·Filed 2013·Granted Aug 28, 2018·6 cites·14 claims
- 1070US12239738B2Compositions and methods for lyophilization of bacteria or listeria strainsADVAXIS INC·Filed 2021·Granted Mar 4, 2025·0 cites·20 claims
- 1163US2025186350A1Compositions and methods for lyophilization of bacteria or listeria strainsADVAXIS INC·Filed 2025·Application pending·0 cites
- 1261US2015366955A9Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumorsADVAXIS INC·Filed 2014·Application pending·0 cites
- 1358US2011129499A1Dual delivery system for heterologous antigensMACIAG PAULO·Filed 2009·Application pending·0 cites
- 1452US2019240303A1Recombinant listeria vaccine strains and methods of producing the sameADVAXIS INC·Filed 2019·Application pending·0 cites
- 1550US2015297702A1Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumorsADVAXIS INC·Filed 2015·Application pending·0 cites
- 1647US2016361401A1Compositions and methods for the treatment of her2/neu over-expressing tumorsADVAXIS INC·Filed 2015·Application pending·0 cites
- 1746US2021003558A1Compositions and methods for evaluating attenuation and infectivity of listeria strainsADVAXIS INC·Filed 2019·Application pending·0 cites
- 1844US2018265879A1Manufacturing method of an immunotherapeutic formulation comprising a recombinant listeria strainADVAXIS INC·Filed 2016·Application pending·0 cites
- 1943US2017368157A1Combination Of Listeria-Based Vaccine With Anti-OX40 Or Anti-GITR AntibodiesADVAXIS INC·Filed 2015·Application pending·0 cites
- 2043US2018153974A1Combination Therapies With Recombinant Listeria StrainsUNIV PENNSYLVANIA·Filed 2015·Application pending·0 cites
- 2143US2021239681A1Compositions and methods for evaluating potency of listeria-based immunotherapeuticsADVAXIS INC·Filed 2019·Application pending·0 cites
- 2241US2018104284A1Immunogenic Listeria-Based Compositions Comprising Truncated Acta-Antigen Fusions And Methods Of Use ThereofADVAXIS INC·Filed 2016·Application pending·0 cites
- 2341US2018064765A1Listeria-based immunogenic compositions for eliciting anti-tumor responsesADVAXIS INC·Filed 2015·Application pending·0 cites
- 2440US2017246273A1Recombinant listeria strain expressing heterologous antigen fusion proteins and methods of use thereofADVAXIS INC·Filed 2015·Application pending·0 cites
- 2540US2017080064A1Methods and compositions for increasing a t-effector cell to regulatory t cell ratioADVAXIS INS·Filed 2015·Application pending·0 cites
- 2638US2012135033A1Multiple delivery system for heterologous antigensWALLECHA ANU·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →